Figure 2From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program Active CML patients as a function of institutional enrollment capacity (Cox proportional hazards regression, adjusted for age, gender, CML initial phase, public institution, presence of ≥ 1 hematologist or oncologist, research ability and technical competency). Back to article page